Eudaimonia Partners’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-9,857
| Closed | -$386K | – | 260 |
|
|
2023
Q3 | $386K | Buy |
9,857
+12
| +0.1% | +$470 | 0.09% | 203 |
|
|
2023
Q2 | $400K | Buy |
9,845
+12
| +0.1% | +$488 | 0.09% | 212 |
|
|
2023
Q1 | $412K | Buy |
9,833
+611
| +7% | +$25.6K | 0.1% | 205 |
|
|
2022
Q4 | $402K | Buy |
9,222
+10
| +0.1% | +$436 | 0.1% | 200 |
|
|
2022
Q3 | $358K | Buy |
9,212
+711
| +8% | +$27.6K | 0.09% | 206 |
|
|
2022
Q2 | $360K | Buy |
8,501
+7
| +0.1% | +$296 | 0.07% | 268 |
|
|
2022
Q1 | $387K | Buy |
+8,494
| New | +$387K | 0.07% | 278 |
|
|
2021
Q3 | $400K | Hold |
8,390
| – | – | 0.07% | 260 |
|
|
2021
Q2 | $407K | Buy |
8,390
+50
| +0.6% | +$2.43K | 0.08% | 256 |
|
|
2021
Q1 | $386K | Buy |
8,340
+100
| +1% | +$4.63K | 0.08% | 238 |
|
|
2020
Q4 | $392K | Buy |
8,240
+265
| +3% | +$12.6K | 0.09% | 216 |
|
|
2020
Q3 | $342K | Buy |
7,975
+2,800
| +54% | +$120K | 0.09% | 215 |
|
|
2020
Q2 | $211K | Buy |
5,175
+300
| +6% | +$12.2K | 0.08% | 228 |
|
|
2020
Q1 | $176K | Buy |
+4,875
| New | +$176K | 0.08% | 234 |
|